The U.S. Food and Drug Administration (FDA) granted full approval to Pfizer-BioNTech’s coronavirus vaccine for those aged 16 and older on Monday.
The two-dose immunization was the first to receive emergency use authorization from federal regulators in December 2020 and will now be first to be licensed.
Full approval by the FDA could push more Americans to get the COVID-19 vaccine because it might reduce their fears about the safety of the shot.
It may also lead to more vaccine mandates with businesses feeling more comfortable requiring workers to get a jab that has full authorization.
CONTINUE READING ON DAILY MAIL
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
- ‘No other way to spin it’: CNN expert says inflation number ‘positive news’ - December 18, 2025
- Fairfax County freed illegal despite ICE request — now a man is dead - December 18, 2025
- US may be entering moderate moment as voters reject radicalism, poll suggests - December 18, 2025
Comment
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.
BPR INSIDER COMMENTS
Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!
